This page is dedicated to the world of Pathology, with tha aim of sharing ideas, knowlegdment, research, curiosity and more else about our big passion!
🔬 She presented an update and overview of pathology diagnosis, molecular alterations and prognosis of genitourinary tumors.
Very happy to have the possibility to learn more about morphology‼️
#benchstormingseminars
#Benchstormingseminars Today @JoseJim77916005, from Molecular Oncology group headed by @PaoloNuciforo explained how clinical trials work and specifically how biopsies from cancer patients are collected and analyzed.
Many thanks to Dr. Eva Muñoz and Dr. Carolina Ortiz for the seminar titled “Melanoma: state of the art”. The therapeutic approach to advanced melanoma is changing dramatically with the approval of new drugs.
#benchstormingseminars
⚡️WE ARE HIRING!⚡️
We are looking for a PhD Student to join our group! Are you interested in MRI, image analysis and artificial intelligence applied to oncology?
Join us!
⏰ Deadline November 11th
👉More info: https://t.co/2o0HujcICY
Please share!
Excited to see how a small research project becomes the project of many. At @VHIO we are ready to assess the functional HRD status of tumors with the RAD51predict test across many cancer types. 🔬👩🔬👩⚕️
Great team work in the groups of @vserra_elizalde@judithbalmana@quimmateo
Today we started with the 1st “Clinical” seminar of the #benchstormingseminars. We have had the pleasure to invite @HelenaVerdaguer, Medical Oncologist of the Gastrointestinal and Endocrine Tumors Group headed by @MacarullaTeresa.
Gran trabajo❗️ Los equipos que trabajan en asistencia e investigación en #CáncerDePáncreas se reúnen regularmente para evaluar nuevos proyectos de investigación y mejorar el tratamiento oncológico.
(2/2) She also talked about the promising patient-derived models generated in the laboratory, which allow studying the mechanisms involved in immune cell recruitment in each tumor isolated from the patient. Thanks Ester❗️
(1/2) #BenchstormingSeminars Today Ester Planas (@EplanasR) from the Gene Expression and Cancer Group led by Dr. Joan Seoane (@seoanelab) presented an innovative approach to predict immune checkpoint inhibitor response in brain tumors.